Methods for determining cost-benefit ratios for pharmaceuticals in Germany

Author： Graf v. d. Schulenburg J.- Vauth Christoph Mittendorf Thomas Greiner Wolfgang

ISSN： 1618-7598

Source： The European Journal of Health Economics, Vol.8, Iss.1, 2007-09, pp. : 5-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost–benefit analysis of an enhanced recovery protocol for pancreaticoduodenectomy

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 13, 2015-12 ,pp. : 1676-1683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Economic evaluation for pharmaceuticals in Germany

By Jönsson Bengt

The European Journal of Health Economics, Vol. 8, Iss. 1, 2007-09 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

Cost-benefit analysis of vector control in areas of potential dengue transmission

By Orellano Pablo Wenceslao Pedroni Elena

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 24, Iss. 2, 2008-08 ,pp. : 113-119

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Cost-benefit of a prevention and treatment program to reduce iron deficiency in Argentina

By Drake Ignacio Bernztein Ricardo

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 25, Iss. 1, 2009-01 ,pp. : 39-46

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite